Author:
Li Zhi–Wen,Lu Xi,Wang Yan–Xiang,Hu Xin–Xin,Fu Hai–Gen,Gao Li–Mei,You Xue–Fu,Tang Sheng,Song Dan–Qing
Funder
CAMS Innovation Fund for Medical Sciences
Fundamental Research Funds for the Central Universities
Subject
Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry
Reference31 articles.
1. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization. 2017.A.J.
2. TIMBER Study Group. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study;Stewardson;Euro. Surveill.,2016
3. C. Elizabeth, S. B. Deitelzweig, B. M. Sherman, A. N. Amin. “Multidrug-Resistant Gram-Negative Bacterial Infections in the Hospital Setting: Overview, Implications for Clinical Practice, and Emerging Treatment Options”. Microbial Drug Resistance (Larchmont, N.Y.). 22 (2016): 412–431.
4. Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe;de Kraker;PLoS Med.,2011
5. World Health Organization. Antibacterial Agents in Clinical Development: An analysis of the antibacterial clinical development pipeline, including tuberculosis. World Health Organization. 2017.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献